Effects of intracoronary infusion of bone marrow-derived stem cells on pulmonary artery pressure and diastolic function after myocardial infarction

International Journal of Cardiology

Volumn 145, Issue 3, 2010, Pages 631-633

  Miettinen, Johanna A ^a   Salonen, Riikka J ^a   Niemelä, Matti ^a   Kervinen, Kari ^a   Säily, Marjaana ^a   Koistinen, Pirjo ^a   Savolainen, Eeva Riitta ^a   Ukkonen, Heikki ^b   Pietilä, Mikko ^b   Airaksinen, K E Juhani ^b   Knuuti, Juhani ^b   Mäkikallio, Timo H ^a   Huikuri, Heikki V ^a   Ylitalo, Kari V ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Diastolic function; Myocardial infarction; Pulmonary artery pressure; Stem cells

Indexed keywords

BONE MARROW; BONE MARROW BIOPSY; CELL THERAPY; CLINICAL TRIAL; DIASTOLE; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; INTRACORONARY INFUSION; LETTER; LUNG ARTERY PRESSURE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; STEM CELL;

EID: 78649979701     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.09.064     Document Type: Article

References (23)

1. B.E. Strauer, M. Brehm, and T. Zeus Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
2. V. Schächinger, B. Assmus, and M.B. Britten Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial J Am Coll Cardiol 44 2004 1690 1699
3. K.C. Wollert, G.P. Meyer, and J. Lotz Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Lancet 364 2004 141 148
4. J. Bartunek, M. Vanderheyden, and B. Vandekerckhove Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety Circulation 112 2005 I178 I183
5. J. Ge, Y. Li, and J. Qian Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI) Heart 92 2006 1764 1767 (Pubitemid 44851319)
6. J. Meluzin, J. Mayer, and L. Groch Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function Am Heart J 152 2006 975.e9-15
7. V. Schächinger, S. Erbs, and A. Elsasser Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction N Engl J Med 355 2006 1210 1221 (Pubitemid 44427445)
8. H.V. Huikuri, K. Kervinen, and M. Niemelä Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction Eur Heart J 29 2008 2723 2732
9. A. Schaefer, G.P. Meyer, and M. Fuchs Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial Eur Heart J 27 2006 929 935
10. S.H. Poulsen, S.E. Jensen, and K. Egstrup Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction Am Heart J 137 1999 910 918
11. A. Deswal Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology Curr Cardiol Rep 7 2005 178 183
12. T. Freyman, G. Polin, and H. Osman A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction Eur Heart J 27 2006 1114 1122
13. M. Kurpisz, R. Czepczynski, and B. Grygielska Bone marrow stem cell imaging after intracoronary administration Int J Cardiol 121 2007 194 195
14. D.L. Kraitchman, M. Tatsumi, and W.D. Gilson Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction Circulation 112 2005 1451 1461
15. G.Y. Rochefort, P. Vaudin, and N. Bonnet Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies? Respir Res 6 2005 125
16. Y.D. Zhao, D.W. Courtman, Y. Deng, L. Kugathasan, Q. Zhang, and D.J. Stewart Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease Circ Res 96 2005 442 450
17. C. Zeng, X. Wang, X. Hu, J. Chen, and L. Wang Autologous endothelial progenitor cells transplantation for the therapy of primary pulmonary hypertension Med Hypotheses 68 2007 1292 1295
18. S. Kanki-Horimoto, H. Horimoto, and S. Mieno Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension Circulation 114 2006 I181 I185
19. X.X. Wang, F.R. Zhang, and Y.P. Shang Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial J Am Coll Cardiol 49 2007 1566 1571
20. K.M. Patel, P. Crisostomo, and T. Lahm Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism J Surg Res 143 2007 281 285
21. J.L. Spees, M.J. Whitney, and D.E. Sullivan Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension FASEB J 22 2008 1226 1236
22. J.E. Moller, G.S. Hillis, J.K. Oh, and P.A. Pellikka Prognostic importance of secondary pulmonary hypertension after acute myocardial infarction Am J Cardiol 96 2005 199 203
23. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150